Skip to main content

Overview

I am interested in working with children with a variety of hematologic disorders.  This includes myeloproliferative neoplasms and bone marrow failure syndromes, blood clotting disorders, and sickle cell anemia.

Current Research Projects

 

Study on pediatric patients with Myeloproliferative Neoplasms

Myeloproliferative Neoplasms (MPN) are diseases of the bone marrow that include Polycythemia Vera, Essential Thrombocytosis, and Myelofibrosis. They are conditions where the bone marrow produces abnormal numbers of blood cells. There are clear genetic causes for the majority of adult patients with these disorders and defined treatment algorithms, but this is not always the case in pediatric patients (where the diseases are much rarer.) I will be collecting blood and buccal samples from pediatric patients with MPN and screening them for a broad array of known genetic abnormalities , as well as evaluating genes that may play a role in myeloid disorders but have not yet been associated with MPN. I will also be developing a pediatric MPN database to gain a better clinical understanding of these disorders in children.  This will hopefully lead to a better understanding of the pathogenesis of these diseases in children and ultimately how to appropriately treat them.


Study of thrombosis in pediatric patients.

There are a number of different reasons why children can get blood clots, and the more we understand about the causes, the better we will do at preventing them. I am working with other members of the pediatrics department to look at which patients in our hospital are getting blood clots, and then trying to develop appropriate prophylaxis guidelines for these children.  Weill Cornell is participating in KIDS-DOTT, a national trial looking at duration of treatment in children.

Highlights

  1. 1
    Journal of pediatric gastroenterology and nutrition · 2021
    PMID: 33616374DOISenior author10 citations
  2. 2
    Pediatric blood & cancer · 2025
    PMID: 40038897DOIFirst author2 citations
  3. 3
    Hematology. American Society of Hematology. Education Program · 2023
    PMID: 38066851PMCID: PMC10727065DOISenior author2 citations

Publications

45 publications

Active

2 grants
  • PI
    ASH AWARDS 2024 - Duffy-null Associated Neutrophil Count (DANC) Health Care System
    American Society of Hematology Inc · 2024–2026
    ASH 235663-01
  • PI
    Analysis of Mutational Spectrum in Pediatric Myeloproliferative Neoplasms
    MPN Research Foundation · 2023–2025
    No publications yet
    MPNRF 226062-01
Completed grants (5)
  • Sub-PI
    Hemophilia Treatment Centers (SPRANS)
    Health Resources and Services Administration · 2020–2022 · via Children's Hospital Los Angeles
    No publications yet
    H30MC240450-09
  • PI
    Pathogenesis and Symptomatology of Pediatric Myeloproliferative Neoplasms
    National Heart, Lung, and Blood Institute · 2017–2022Career
    K23HL127223-04
  • PI
    Honors Program Offer- CSOM Student
    American Society of Hematology Inc · 2020–2021
    ASH 204940-01
  • Sub-PI
    Prospective Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT)
    National Heart, Lung, and Blood Institute · 2017–2021 · via All Children's Research Institute, Inc.
    U01HL130048-04
  • Sub-PI
    Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
    The Johns Hopkins University · 2014–2018 · via All Children's Research Institute, Inc.
    ACRII 14121795-02

Clinical research

1 study
Completed & closed trials (1)
  • PI
    Validating and Developing Duffy Null Specific Absolute Neutrophil Count Reference Ranges for Adults and Pediatrics
    American Society of Hematology Inc · IRB STUDY CLOSURE (as of 2025)

External relationships

Other

Protagonist Therapeutics, Inc.